These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 9787943

  • 1. Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.
    Sarmiento JM, Munn SR, Paya CV, Velosa JA, Nguyen JH.
    Clin Transplant; 1998 Oct; 12(5):371-4. PubMed ID: 9787943
    [Abstract] [Full Text] [Related]

  • 2. Does mycophenolate mofetil increase the incidence of cytomegalovirus disease compared with azathioprine after cadaveric kidney transplantation?
    Basic-Jukic N, Kes P, Bubic-Filipi LJ, Puretic Z, Brunetta B, Pasini J.
    Transplant Proc; 2005 Mar; 37(2):850-1. PubMed ID: 15848553
    [Abstract] [Full Text] [Related]

  • 3. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F, Serón D, Morales JM, Cruzado JM, Gil-Vernet S, Pérez JL, Fulladosa X, Andrés A, Grinyó JM.
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [Abstract] [Full Text] [Related]

  • 4. Cytomegalovirus risk factors in renal transplantation with modern immunosuppression.
    Bataille S, Moal V, Gaudart J, Indreies M, Purgus R, Dussol B, Zandotti C, Berland Y, Vacher-Coponat H.
    Transpl Infect Dis; 2010 Dec; 12(6):480-8. PubMed ID: 20629971
    [Abstract] [Full Text] [Related]

  • 5. Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction.
    Smak Gregoor PJ, van Gelder T, van Besouw NM, van der Mast BJ, IJzermans JN, Weimar W.
    Transplantation; 2000 Jul 15; 70(1):143-8. PubMed ID: 10919591
    [Abstract] [Full Text] [Related]

  • 6. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
    Bernabeu-Wittel M, Naranjo M, Cisneros JM, Cañas E, Gentil MA, Algarra G, Pereira P, González-Roncero FJ, de Alarcón A, Pachón J.
    Eur J Clin Microbiol Infect Dis; 2002 Mar 15; 21(3):173-80. PubMed ID: 11957018
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW.
    Clin Transplant; 1997 Aug 15; 11(4):299-312. PubMed ID: 9267719
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil in liver transplantation.
    McDiarmid SV.
    Clin Transplant; 1996 Feb 15; 10(1 Pt 2):140-5. PubMed ID: 8680052
    [Abstract] [Full Text] [Related]

  • 9. Lower incidence of cytomegalovirus infection with everolimus versus mycophenolate mofetil in de novo cardiac transplant recipients: a randomized, multicenter study.
    Viganò M, Dengler T, Mattei MF, Poncelet A, Vanhaecke J, Vermes E, Kleinloog R, Li Y, Gezahegen Y, Delgado JF, RAD A2411 Study Investigators.
    Transpl Infect Dis; 2010 Feb 15; 12(1):23-30. PubMed ID: 19744284
    [Abstract] [Full Text] [Related]

  • 10. [Factors influencing prevalence and clinical course of cytomegalovirus (CMV) infection in kidney transplant patients].
    Szymczakiewicz-Multanowska AM, Kuźniewski M, Zawilińska B, Zgórniak-Nowosielska I, Uracz D, Ignacak E, Betkowska-Prokop A, Sułowicz W.
    Przegl Lek; 2001 Feb 15; 58(7-8):772-7. PubMed ID: 11769385
    [Abstract] [Full Text] [Related]

  • 11. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 12. The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation.
    ter Meulen CG, Wetzels JF, Hilbrands LB.
    Nephrol Dial Transplant; 2000 May 15; 15(5):711-4. PubMed ID: 10809816
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group.
    Am J Kidney Dis; 1999 Aug 15; 34(2):296-303. PubMed ID: 10430977
    [Abstract] [Full Text] [Related]

  • 14. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection.
    Palmer SM, Baz MA, Sanders L, Miralles AP, Lawrence CM, Rea JB, Zander DS, Edwards LJ, Staples ED, Tapson VF, Davis RD.
    Transplantation; 2001 Jun 27; 71(12):1772-6. PubMed ID: 11455257
    [Abstract] [Full Text] [Related]

  • 15. [Infectious complications in using mofetil micofenolate in patients with renal allotransplant].
    Prokopenko EI, Shcherbakova EO, Vatazin AV, Kruglov EE, Pasov SA, Budnikova NE, Agafonova SG, Rusanova EV.
    Ter Arkh; 2005 Jun 27; 77(1):67-72. PubMed ID: 15759459
    [Abstract] [Full Text] [Related]

  • 16. Increased risk of complicated CMV infection with the use of mycophenolate mofetil in allogeneic stem cell transplantation.
    Hambach L, Stadler M, Dammann E, Ganser A, Hertenstein B.
    Bone Marrow Transplant; 2002 Jun 27; 29(11):903-6. PubMed ID: 12080355
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. German Pediatric Renal Transplantation Study Group.
    Staskewitz A, Kirste G, Tönshoff B, Weber LT, Böswald M, Burghard R, Helmchen U, Brandis M, Zimmerhackl LB.
    Transplantation; 2001 Mar 15; 71(5):638-44. PubMed ID: 11292293
    [Abstract] [Full Text] [Related]

  • 18. What is the role for mycophenolate mofetil in pediatric renal transplantation?
    Neu AM, Benfield M.
    Pediatr Transplant; 1999 Feb 15; 3(1):83-7. PubMed ID: 10359037
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients.
    Sarmiento JM, Dockrell DH, Schwab TR, Munn SR, Paya CV.
    Clin Transplant; 2000 Apr 15; 14(2):136-8. PubMed ID: 10770418
    [Abstract] [Full Text] [Related]

  • 20. Combination therapy with diltiazem plus CsA/MMF/Pred or CsA/Aza/Pred triple immunosuppressive regimens for use in clinical kidney transplantation in Northwestern China.
    Song Y, Xue W, Tian P, Ding X, Pan X, Yan H, Hou J, Feng X, Xiang H, Tian X, Qin G, Fan X.
    Eur J Clin Pharmacol; 2011 Jun 15; 67(6):553-62. PubMed ID: 21279337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.